Provided by Tiger Trade Technology Pte. Ltd.

Allogene Therapeutics Inc.

2.33
+0.12005.43%
Post-market: 2.350.0193+0.83%17:04 EDT
Volume:4.40M
Turnover:10.20M
Market Cap:568.00M
PE:-2.69
High:2.37
Open:2.27
Low:2.26
Close:2.21
52wk High:2.80
52wk Low:0.8621
Shares:243.78M
Float Shares:168.00M
Volume Ratio:0.48
T/O Rate:2.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8652
EPS(LYR):-0.8652
ROE:-53.42%
ROA:-26.82%
PB:1.94
PE(LYR):-2.69

Loading ...

Feb 25, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 15, 2020

Major Issues Report

8-K - Current report
Dec 07, 2020

Major Issues Report

8-K - Current report
Nov 04, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2020

Major Issues Report

8-K - Current report
Oct 26, 2020

Major Issues Report

8-K/A [Amend] - Current report
Aug 10, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2020

Major Issues Report

8-K - Current report
Jul 10, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 11, 2020

Major Issues Report

8-K - Current report
Jun 04, 2020

Major Issues Report

8-K - Current report
May 29, 2020

Major Issues Report

8-K - Current report
May 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2020

Major Issues Report

Current report, items 2.02 and 9.01